User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 05:14, 31 March 2021 (diff | hist) . . (-2) . . 3.2.3 Implementation of the EQIPD Quality System
- 05:13, 31 March 2021 (diff | hist) . . (-233) . . 3.2.3 Implementation of the EQIPD Quality System
- 06:15, 30 March 2021 (diff | hist) . . (+28) . . Glossary
- 06:13, 30 March 2021 (diff | hist) . . (+176) . . Glossary
- 11:23, 29 March 2021 (diff | hist) . . (+118) . . Glossary
- 06:49, 25 March 2021 (diff | hist) . . (+69) . . 1.4.3.2 Industry-academia: Research as collaboration (→Background)
- 06:48, 25 March 2021 (diff | hist) . . (+181) . . 1.4.3.2 Industry-academia: Research as collaboration (→Background)
- 06:46, 25 March 2021 (diff | hist) . . (+22) . . 1.4.3.2 Industry-academia: Research as collaboration (→Expectations)
- 06:44, 25 March 2021 (diff | hist) . . (+3,543) . . 1.4.3.2 Industry-academia: Research as collaboration (→Expectations)
- 06:42, 25 March 2021 (diff | hist) . . (+16) . . 1.4.3.2 Industry-academia: Research as collaboration (→Background)
- 06:42, 25 March 2021 (diff | hist) . . (+1,334) . . 1.4.3.2 Industry-academia: Research as collaboration (→Background and Expectations)
- 06:40, 25 March 2021 (diff | hist) . . (-20) . . 1.4.3.2 Industry-academia: Research as collaboration (→C. Resources)
- 06:40, 25 March 2021 (diff | hist) . . (+191) . . 1.4.3.2 Industry-academia: Research as collaboration (→Resources)
- 06:38, 25 March 2021 (diff | hist) . . (-3) . . 1.4.3 Quality in collaborative research (→C. Resources) (current)
- 13:32, 17 March 2021 (diff | hist) . . (+1,587) . . N 1.4.3.1 Industry-academia: Research as service (Created page with "=Background and Expectations= A significant percentage of drug discovery and development efforts is outsourced to external service providers. Biopharmaceutical industry aims...")
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
